CN105497400A - 一种治疗肾虚痰湿型月经过少的药物组合物 - Google Patents
一种治疗肾虚痰湿型月经过少的药物组合物 Download PDFInfo
- Publication number
- CN105497400A CN105497400A CN201610060138.XA CN201610060138A CN105497400A CN 105497400 A CN105497400 A CN 105497400A CN 201610060138 A CN201610060138 A CN 201610060138A CN 105497400 A CN105497400 A CN 105497400A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- kidney
- caulis
- phlegm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 68
- 206010062717 Increased upper airway secretion Diseases 0.000 title claims abstract description 42
- 208000026435 phlegm Diseases 0.000 title claims abstract description 42
- 208000037093 Menstruation Disturbances Diseases 0.000 title claims abstract description 37
- 206010021033 Hypomenorrhoea Diseases 0.000 title claims abstract description 36
- 229940079593 drug Drugs 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 title claims abstract description 11
- 210000003734 kidney Anatomy 0.000 claims abstract description 62
- 230000007812 deficiency Effects 0.000 claims abstract description 35
- 238000011282 treatment Methods 0.000 claims description 48
- 241000688694 Cheilanthes argentea Species 0.000 claims description 34
- 239000008194 pharmaceutical composition Substances 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 238000002481 ethanol extraction Methods 0.000 claims description 25
- 238000002360 preparation method Methods 0.000 claims description 19
- 239000002775 capsule Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 239000004615 ingredient Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 5
- 239000000469 ethanolic extract Substances 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- -1 sublimed preparation Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 35
- 210000004369 blood Anatomy 0.000 abstract description 35
- 230000000694 effects Effects 0.000 abstract description 15
- 208000024891 symptom Diseases 0.000 abstract description 11
- 230000002175 menstrual effect Effects 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 241000183291 Aleuritopteris Species 0.000 abstract 1
- 241000530400 Boerhavia Species 0.000 abstract 1
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 241000522190 Desmodium Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 206010027339 Menstruation irregular Diseases 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000606278 Triplostegia Species 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 230000000149 penetrating effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000005906 menstruation Effects 0.000 description 21
- 230000017531 blood circulation Effects 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 239000003390 Chinese drug Substances 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 11
- 230000027758 ovulation cycle Effects 0.000 description 11
- 208000019255 Menstrual disease Diseases 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000004696 endometrium Anatomy 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000004914 menses Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 208000021267 infertility disease Diseases 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000003821 menstrual periods Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000004080 punching Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- RSEPBGGWRJCQGY-RBRWEJTLSA-N Estradiol valerate Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2 RSEPBGGWRJCQGY-RBRWEJTLSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000034579 Acute haemorrhagic conjunctivitis Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010049949 Intercostal neuralgia Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 206010036049 Polycystic ovaries Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 201000006828 endometrial hyperplasia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 231100000545 luteal phase defect Toxicity 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000011450 sequencing therapy Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药领域,涉及治疗月经不调的药物,尤其涉及一种治疗肾虚痰湿型月经过少的药物组合物。该药物组合物由巴戟天、熟地黄、刺五加、水茴香、法半夏、黑血藤、老来青、佛手、双参、红母鸡草、通经草、香附为原料药精心制成。全方合伍,温肾助阳,补肾填精,燥湿化痰,活血化瘀,和血调经之功效,抓住患者肾虚之本,痰湿之标兼顾,使肾精足,肾气盛,痰湿祛,冲任二脉通,气血调和,通路无阻,则月经量正常。
Description
技术领域
本发明属于中药领域,涉及治疗月经不调的药物,尤其涉及一种治疗肾虚痰湿型月经过少的药物组合物。
背景技术
月经过少是月经周期正常,月经量明显减少,或行经时间不足2天,甚或点滴即。月经过少是育龄期妇女的常见病,若不及时治疗,可发展成闭经、不孕。而随着社会的发展,环境的变迁,该病的发病率正逐年升高,特别是宫腔操作因素所占比例越来越高。
中医认为,月经是脏腑、天癸、气血、经络协调作用在胞宫的生理现象,月经的正常来潮与肾-天癸-冲任-胞宫的生理功能密切相关。《内经》:“肾气盛,天癸至,月事以时下”阐明了月经产生的机制是以肾为主导。肾主藏精,既藏先天之精,又藏后天之精,精能生血,血能化精,精血同源而互相资生,成为月经的物质基础。肾精所化肾气,肾气充盛,冲任二脉之血旺盛,气血调和,月经方能正常来潮。所以肾主宰着天癸的至与竭与月经的潮与止。《傅青主女科》认为:“经水出诸肾。”《医学正传·妇人科》曰:“月水全赖肾水施化,肾水既乏,则经血自以干涸”,说明肾是月经产生的根本,肾中精气的盛衰是保证月经正常来潮的基础,肾水亏乏,则经血渐而闭塞不通,甚者干涸。
中医学总结认为该病病机多为肾虚、血虚、血瘀、痰湿、肝郁气滞等,治疗上以辨证论治。月经过少的各个证型有各自不同的临床特征,为临床辨证提供了依据。但月经过少病因复杂,者个体差异较甚,中医药对部分月经量少患者的疗效并不明显。西方医学认为月经过少为一临床症状,对其研究较少,治疗上以病因治疗为主,往往效果不甚明显。因此,需要提出一种具有更好疗效的治疗月经过少的中药复合物的中药。
发明内容
本发明所要解决的技术问题在于,利用我国传统的中医理论,提供一种治疗月经过少,尤其是中医辩证证属肾虚痰湿型的药物组合物及其制备方法。该药物组合物组方严谨,配伍科学,疗效显著,患者依从性好,无毒副作用。
本发明提供的一种治疗肾虚痰湿型月经过少的药物组合物,其由巴戟天、熟地黄、刺五加、水茴香、法半夏、黑血藤、老来青、佛手、双参、红母鸡草、通经草、香附为原料药精心制成。方中各原料药的重量份配比如下:巴戟天8-18份、熟地黄20-30份、刺五加11-19份、水茴香5-15份、法半夏10-20份、黑血藤8-18份、老来青20-30份、佛手5-13份、双参20-40份、红母鸡草10-30份、通经草5-15份、香附5-15份。
进一步地,一种治疗肾虚痰湿型月经过少的药物组合物,其特征在于由下述重量份配比的原料药制成:巴戟天8-13份、熟地黄25-30份、刺五加13-18份、水茴香5-9份、法半夏10-15份、黑血藤9-15份、老来青22-27份、佛手8-13份、双参26-34份、红母鸡草12-18份、通经草7-12份、香附8-13份。
进一步地,一种治疗肾虚痰湿型月经过少的药物组合物,其特征在于由下述重量份配比的原料药制成:巴戟天10份、熟地黄25份、刺五加15份、水茴香8份、法半夏12份、黑血藤15份、老来青25份、佛手12份、双参30份、红母鸡草15份、通经草10份、香附12份。
发明人认为:患者或为先天禀赋不足,肾气不盛,胞宫发育迟缓,冲任精血不足,血海满盈不足导致月经量少;或为房劳多产耗伤肾精,冲任精血不足,血海满盈不足导致月经量少;或为肾虚及脾,水湿不化,聚湿为痰,痰湿壅塞冲任,精血下行受阻,导致月经量少,证属肾虚痰湿,症见月经量少,色淡红,质粘腻,形体肥胖,腰膝酸软,舌淡苔白腻,有齿痕,脉细滑。方中:巴戟天辛甘,温,性能补助元阳,补中益气;刺五加辛、微苦,温,益气健脾,补肾安神,活血通络;熟地黄甘,微温,滋阴补血,益精填髓,三药伍用,滋阴补阳,化气生精,补肾调经为君药。水茴香辛,甘,温,健脾利湿,理气化痰;法半夏辛、温,燥湿化痰二药伍用燥湿化痰力强,为臣药。黑血藤补血活血,清肺润燥,通经活络;老来青活血散瘀,强筋骨,调经,佛手舒肝理气,和胃止痛;双参健脾益肾,活血调经;红母鸡草祛瘀调经;通经草祛痰止咳,活血通经,利湿解毒消肿;香附行气解郁,调经,共为佐药。全方合伍,温肾助阳,补肾填精,燥湿化痰,活血化瘀,和血调经之功效,抓住患者肾虚之本,痰湿之标兼顾,使肾精足,肾气盛,痰湿祛,冲任二脉通,气血调和,通路无阻,则月经量正常。
本发明药物组合物所用原料的研究现状如下所述:
巴戟天:【性味】辛甘;温。【归经】肝;肾经。【功能主治】补肾助阳;强筋壮骨;祛风除湿。主肾虚阳痿;遗精早泄;少腹冷痛;小便不禁;宫冷不孕;风寒湿痹;腰膝酸软;风湿肢气。
熟地黄:【性味】甘,微温。【归经】归肝、肾经。【功能主治】滋阴补血,益精填髓。用于肝肾阴虚,腰膝酸软,骨蒸潮热,盗汗遗精,内热消渴,血虚萎黄,心悸怔忡,月经不调,崩漏下血,眩晕,耳鸣,须发早白。
刺五加:【性味】辛、微苦,温。【归经】归脾、肾、心经。【功能主治】益气健脾,补肾安神。用于脾肾阳虚,体虚乏力,食欲不振,腰膝酸痛,失眠多梦。
水茴香:【性味】味辛;甘;性温。【归经】归肺;脾;胃经。【功能主治】健脾利湿;理气化痰。主水肿;胃痛;胸腹胀满;咳嗽;小儿乳积;疮疖【用法用量】内服:煎汤,10-15g。外用:适量,捣敷;或煎水洗。
法半夏:【性味】辛、温。【归经】归脾、胃、肺经。【功能主治】燥湿化痰。用于痰多咳喘,痰饮眩悸,风痰眩晕,痰厥头痛。
黑血藤:【性味】苦;涩;性凉【归经】入肝、肾二经。【功能主治】补血活血;清肺润燥;通经活络。主贫血;有经不调;肺热燥咳;咳血;腰膝酸痛;风湿痹痛;手足麻木;瘫痪。【用法用量】内服:煎汤15-30g;或泡酒。外用:适量,煎水熏洗;或炒热包敷。【各家论述】《新华本草纲要》:老茎:味涩、性凉。有补血、活血、通经壮骨的功能。用于风湿痹痛,贫血,萎黄病,月经不调,腰腿痛,瘫痪。
老来青:【性味】苦、辛,温。【功能主治】活血散瘀,强筋骨,调经,消疳;用于筋骨疼痛,腰腿痛,月经不调,白带,胃纳不佳,脾肾虚浮肿,虚咳,小儿疳积。
佛手:【性味】辛、苦、酸,温。【归经】归肝、脾、肺经。【功能主治】舒肝理气,和胃止痛。用于肝胃气滞,胸胁胀痛,胃脘痞满,食少呕吐。【用法用量】3~9g。
双参:【性味】甘、微苦,平。【功能主治】健脾益肾,活血调经,止崩漏,解毒。用于肾虚腰痛,贫血,咳嗽,遗精,阳萎,风湿关节痛,月经不调,倒经,崩漏,带下,不孕症。外用止血。
红母鸡草:【性味】甘辛;平。【归经】肝经。【功能主治】祛瘀调经,解毒,止痛。主跌打损伤,子宫脱垂,脱肛,闭经,牛皮癣,牙痛,头痛。【用法用量】内服:煎汤,9-15g。外用:适量,捣敷;或制成膏剂涂搽。
通经草:【性味】辛;甘;平。【归经】肺;肝经。【功能主治】祛痰止咳;活血通经;利湿;解毒消肿。主咳嗽;月经不调;经闭腹痛;赤白带下;肺痨咳血;大便泄泻;小便涩痛;肺痈;乳痈;风湿关节痛;跌打损伤;肋间神经痛;暴发火眼;疮肿。【用法用量】内服:煎汤,9-15g。外用:适量,水煎熏洗;或捣敷。
香附:【性味】辛、微苦、微甘,平。【归经】归肝、脾、三焦经。【功能主治】行气解郁,调经止痛。用于肝郁气滞,胸、胁、脘腹胀痛,消化不良,胸脘痞闷,寒疝腹痛,乳房胀痛,月经不调,经闭痛经。
本发明所提供的治疗肾虚痰湿型月经过少的药物组合物,可以直接将巴戟天、熟地黄、刺五加、水茴香、法半夏、黑血藤、老来青、佛手、双参、红母鸡草、通经草、香附粉碎,制备成粉散剂口服;也可以将各组分直接混合制成粗粉,萃取出粗粉中的有效成分制成浸膏,利用浸膏制备成口服剂型,如片剂、薄膜衣片剂、肠溶衣片剂、胶囊剂、硬胶囊剂、软胶囊剂、口服液、颗粒剂、蜜丸剂、散剂、丹剂、溶液剂等,还可以制备成适于治疗多囊卵巢综合征合并不孕的其它剂型。
发明人综合考虑处方量、药物性质、用药对象、使用方便、制作成本等因素,优选制成胶囊剂、片剂、颗粒剂;最优选制成胶囊剂,即将各组分直接混合制成粗粉,萃取出粗粉中的有效成分制,该有效成分单独或与药物可接受的载体混合,依照制剂学常规技术制备而成。
本发明还提供了一种上述所述药物组合物的制备方法,本发明的发明人在研究中发现,通过优化制备方法,能够在保持有效药物的情况下,去除杂质或无药效的部分,减少杂质对治疗效果的干扰,使得该药物组合物更加有效,并且由此减少药物的用量,本发明提供的该药物组合物的制备方法,它包括如下步骤:
将水茴香、红母鸡草、通经草、香附加55%-60%的乙醇提取二次,每次1.5-2.0小时,收集乙醇提取液及乙醇提取物滤渣,减压浓缩成干浸膏,冷冻干燥,粉碎得乙醇提取物;将巴戟天、熟地黄、刺五加、法半夏、黑血藤、老来青、佛手、双参连同水茴香、红母鸡草、通经草、香附乙醇提取物滤渣加水煎煮二次,合并煎液,滤过,滤液减压浓缩至相对密度为1.05-1.10(60℃测得),加入乙醇使含醇量达35%,于0-10℃静置12小时,滤过,滤液回收乙醇后减压浓缩成干浸膏,粉碎后与水茴香、红母鸡草、通经草、香附乙醇提取物混匀,作为有效成分,该成分单独或与药物可接受的载体混合,依照制剂学常规技术制成。
本发明的药物组合物在使用时根据病人的情况确定用法用量。本发明的药物组合物在使用时根据病人的情况确定用法用量,可每日服1-3次,每次1-20剂,如:1-20袋或粒或片。
本发明是发明人经过反复研究,逐步改进,最后成功的一种疗效较好的药物组合物,并通过临床病例进一步验证了本发明药物组合物的疗效,详细资料如下所述:
1资料与方法
1.1一般资料:观察2013年12月至2014年12月就诊于我院妇科门诊确诊为月经量少证属肾虚痰湿型、获取知情同意且自愿参加本研究的患者108例,采用随机分组,单盲方法,将病例按年龄、病情轻重不同分为中药组与西药组,每组54例。中药组最大年龄36岁,最小年龄18岁,平均年龄27.3±3.56岁,西药组最大年龄38岁,最小年龄18岁,平均26.9±3.73岁;中药组病程最长5.5年,最短8个月,平均2.85±1.23年,西药组病程最长5.5年,最短9个月,平均2.96±1.17年,两组一般资料比较无统计学差异(P>0.05),具有可比性。
1.2诊断标准:按照《中医妇科学》和中华人民共和国卫生部2002年颁布的《中药新药治疗月经不调的临床研究指导原则》的月经过少的诊断标准。
月经过少:月经过少是指月经周期正常,月经血量较常量明显减少,甚至点滴即净,或经行时间不足2天,经量亦少的月经病。
中医辨证标准:肾虚痰湿证:经行涩少,色淡红,质粘腻,形体肥胖,腰膝酸软,舌淡苔白腻,有齿痕,脉细滑。
1.3排除标准:有内分泌异常、黄体功能不全、宫腔器质性病变者;有甲状腺功能亢进、结核、严重贫血等慢性消耗性疾病者;3个月内有口服激素、使用避孕药者;服药过程中出现不良反应者;未按规定用药,无法判断疗效或资料不全等影响疗效或统计处理者。
1.4治疗方法:
中药组:月经第5天开始使用本发明实施例1制备的胶囊剂,每日2次,每次2-4粒,以3个月为一个疗程,连续服用3个月。经期如无特殊不停药,服药期间,嘱患者少食油腻、高糖、生冷食物。
西药组:使用西药行人工周期雌孕激素序贯疗法,从月经第5天开始,患者口服补佳乐1mg,1次/d,连服21d;自第15天开始,加用黄体酮胶丸100mg,2次/d,服至第21天与补佳乐同时停药。连续治疗3个月经周期。
1.5治疗前后观察指标:
1.5.1月经情况的改变--月经量色、质,行经时间,月经周期。
1.5.2治疗前后症状评分,标准:轻度:8分以下,中度:8.5~12.5分;重度:13分以上。主要症状评分标准:月经减少1/3或不足2d,整个月经周期用7~10块纸垫5分;减少1/2,共用纸垫3~6块6分;月经点滴即净,用纸垫1~2块7分。伴有小腹或少腹冷痛2分,痛经1分,畏寒肢冷1分,脉细滑0.5分,苔薄白或白腻0.5分,带下量多0.5分,腰骶酸痛0.5分。
1.5.3记录两组治疗前后患者子宫内膜厚度;
1.5.4用药期间药物不良反应的观察:观察用药期间有无出现不良反应并记录,如胃肠道不适、过敏反应、阴道出血时间延长等。如出现严重不良反应者,立即停止用药,退出本研究。
1.6疗效标准:根据《中药新药治疗月经不调的临床研究指导原则》,拟定以下疗效标准:痊愈:治疗后月经周期、经量恢复正常,其他症状消失,停药3个月经周期未复发者。显效:月经量增加1/3,其他症状消失减轻,积分较治疗前减少70%,停药3个月经周期无复发者。有效:治疗后月经周期、经量、经期较治疗前改善,其他症状较治疗前减轻,积分较治前减少30~69%。无效:治疗后月经周期、经量及经期无改善,积分较治疗前减少30%以下。总有效率=(痊愈+显效+有效)/总病例数X100%,显效率=(痊愈+显效)/总病例数X100%。
1.7统计学方法:采用SPSS16.0统计软件进行计算。各数值以表示,计量资料采用t检验,计数资料采用χ2检验,以P<0.05为差异有统计学意义。
2结果
2.1两组患者疗效比较:治疗后,中药组治愈24例,显效18例,好转11例,无效1例,显效率77.8%,总有效率98.1%;西药组治愈12例,显效12例,好转17例,未愈13例,显效率44.4%,总有效率75.9%,中药组与西药组显效率、总有效率比较,差异有统计学意义(P<0.05)。见表1。
表1两组患者疗效比较(n%,例)
注:与西药组比较,*P<0.05。
2.2两组症状积分比较:治疗后两组症状积分均明显较少,与治疗前比较差异有统计学意义(P<0.01),治疗后两组间比较,差异有统计学意义(P<0.05),中药组症状积分减少更加明显。见表2。
表2治疗前后两组症状积分比较
注:与治疗前比较,*P<0.05,**P<0.01,治疗后与西药组比较,#P<0.05。
2.3两组患者治疗前后子宫内膜厚度比较:治疗后中药组子宫内膜厚度较治疗前增加,与治疗前比较,差异有统计学意义(P<0.05),西药组治疗前后子宫内膜厚度无明显改变,治疗前后比较差异无统计学意义(P>0.05);治疗后组间比较,差异有统计学意义(P<0.05),说明中药组增加子宫内膜厚度的疗效优于西药组。见表3。
表3两组治疗前后子宫内膜厚度比较
注:与治疗前比较,*P<0.05,治疗后与西药组比较,#P<0.05。
2.4用药期间药物不良反应的观察:西药组治疗的患者中15例患者出现恶心,胃胀等胃肠道反应,经对症治疗后好转;中药组未诉不适,两组比较,差异有统计学意义(P<0.01)。
总之:本研究结果表明:中药组患者临床痊愈率、总有效率均明显优于西药组,治疗后组间比较差异有统计学意义(P<0.05)。同时,本发明药物可显著缓解肾虚痰湿型月经过少患者临床症状,同时还能促进子宫内膜增生。因此,本发明还请求保护上述药物组合物在制备治疗肾虚痰湿型月经过少的药物中的用途。
本发明相对与现有技术,有如下明显优势:
首先,本发明药物组合物符合中医药学和现代医药学理论,立法全面,用药周到,全方共奏温肾助阳,补肾填精,燥湿化痰,活血化瘀,和血调经之功效,针对肾虚痰湿型月经过少的病机特点研制而成,针对性疗效好。
本发明组合物的组分均采用天然的中药原料,其配制简便、药源广、成本低。其遵循中医的处方用药原则,作用可靠,药性平和,未出现毒副作用,能够达到标本兼治的目的。
本发明中药制剂采用先进提取设备和工艺,充分提取有效成分,可制成方便口服或携带的中药制剂,如片剂、胶囊剂或颗粒剂。
具体实施方式
以下通过具体实施例进一步描述本发明,本发明不仅仅限于以下实施例。在本发明的范围内或者在不脱离本发明的内容、精神和范围内,对本发明进行的变更、组合或替换,对于本领域的技术人员来说是显而易见的,且包含在本发明的范围之内。
实施例1胶囊剂
处方:巴戟天10份、熟地黄25份、刺五加15份、水茴香8份、法半夏12份、黑血藤15份、老来青25份、佛手12份、双参30份、红母鸡草15份、通经草10份、香附12份。
制备方法:将水茴香、红母鸡草、通经草、香附加55%-60%的乙醇提取二次,每次1.5-2.0小时,收集乙醇提取液及乙醇提取物滤渣,减压浓缩成干浸膏,冷冻干燥,粉碎得乙醇提取物;将巴戟天、熟地黄、刺五加、法半夏、黑血藤、老来青、佛手、双参连同水茴香、红母鸡草、通经草、香附乙醇提取物滤渣加水煎煮二次,合并煎液,滤过,滤液减压浓缩至相对密度为1.05-1.10(60℃测得),加入乙醇使含醇量达35%,于0-10℃静置12小时,滤过,滤液回收乙醇后减压浓缩成干浸膏,粉碎后与水茴香、红母鸡草、通经草、香附乙醇提取物混匀,作为有效成分,依照制剂学常规技术制成本。
本实施例制得的胶囊剂,每粒含有生药0.9g。
实施例2胶囊剂
处方:巴戟天10份、熟地黄20份、刺五加12份、水茴香10份、法半夏15份、黑血藤18份、老来青22份、佛手10份、双参26份、红母鸡草12份、通经草9份、香附12份。
制备方法:参照实施例1。
实施例3胶囊剂
处方:巴戟天8份、熟地黄25份、刺五加15份、水茴香9份、法半夏10份、黑血藤12份、老来青22份、佛手10份、双参30份、红母鸡草18份、通经草8份、香附10份。
制备方法:参照实施例1。
实施例4胶囊剂
处方:巴戟天12份、熟地黄28份、刺五加16份、水茴香9份、法半夏15份、黑血藤10份、老来青27份、佛手8份、双参35份、红母鸡草12份、通经草12份、香附12份。
制备方法:参照实施例1。
实施例5胶囊剂
处方:巴戟天15份、熟地黄30份、刺五加18份、水茴香5份、法半夏15份、黑血藤10份、老来青20份、佛手12份、双参34份、红母鸡草16份、通经草12份、香附12份。
制备方法:参照实施例1。
实施例6胶囊剂
处方:巴戟天10份、熟地黄20份、刺五加11份、水茴香15份、法半夏10份、黑血藤10份、老来青25份、佛手8份、双参28份、红母鸡草12份、通经草8份、香附12份。
制备方法:参照实施例1。
实施例7颗粒剂
处方:巴戟天12份、熟地黄26份、刺五加14份、水茴香7份、法半夏14份、黑血藤14份、老来青24份、佛手10份、双参30份、红母鸡草15份、通经草10份、香附12份。
制备方法:将水茴香、红母鸡草、通经草、香附加55%-60%的乙醇提取二次,每次1.5-2.0小时,收集乙醇提取液及乙醇提取物滤渣,减压浓缩成干浸膏,冷冻干燥,粉碎得乙醇提取物;将巴戟天、熟地黄、刺五加、法半夏、黑血藤、老来青、佛手、双参连同水茴香、红母鸡草、通经草、香附乙醇提取物滤渣加水煎煮二次,合并煎液,滤过,滤液减压浓缩至相对密度为1.05-1.10(60℃测得),加入乙醇使含醇量达35%,于0-10℃静置12小时,滤过,滤液回收乙醇后减压浓缩成干浸膏,粉碎后与水茴香、红母鸡草、通经草、香附乙醇提取物混匀,作为有效成分,依照制剂学常规技术制成本。
本实施例制得的颗粒剂,每袋含有生药3.0g。
实施例8片剂
处方:巴戟天12份、熟地黄30份、刺五加15份、水茴香9份、法半夏14份、黑血藤10份、老来青30份、佛手12份、双参35份、红母鸡草15份、通经草12份、香附12份。
制备方法:将水茴香、红母鸡草、通经草、香附加55%-60%的乙醇提取二次,每次1.5-2.0小时,收集乙醇提取液及乙醇提取物滤渣,减压浓缩成干浸膏,冷冻干燥,粉碎得乙醇提取物;将巴戟天、熟地黄、刺五加、法半夏、黑血藤、老来青、佛手、双参连同水茴香、红母鸡草、通经草、香附乙醇提取物滤渣加水煎煮二次,合并煎液,滤过,滤液减压浓缩至相对密度为1.05-1.10(60℃测得),加入乙醇使含醇量达35%,于0-10℃静置12小时,滤过,滤液回收乙醇后减压浓缩成干浸膏,粉碎后与水茴香、红母鸡草、通经草、香附乙醇提取物混匀,作为有效成分,依照制剂学常规技术制成本。
本实施例制得的片剂,每片含有生药0.8g。
Claims (9)
1.一种治疗肾虚痰湿型月经过少的药物组合物,其特征在于由巴戟天、熟地黄、刺五加、水茴香、法半夏、黑血藤、老来青、佛手、双参、红母鸡草、通经草、香附为原料药精心制成。
2.如权利要求1所述的治疗肾虚痰湿型月经过少的药物组合物,其特征在于由下述优选重量份配比的原料药制成:巴戟天8-18份、熟地黄20-30份、刺五加11-19份、水茴香5-15份、法半夏10-20份、黑血藤8-18份、老来青20-30份、佛手5-13份、双参20-40份、红母鸡草10-30份、通经草5-15份、香附5-15份。
3.如权利要求2所述的治疗肾虚痰湿型月经过少的药物组合物,其特征在于由下述优选重量份配比的原料药制成:巴戟天8-13份、熟地黄25-30份、刺五加13-18份、水茴香5-9份、法半夏10-15份、黑血藤9-15份、老来青22-27份、佛手8-13份、双参26-34份、红母鸡草12-18份、通经草7-12份、香附8-13份。
4.如权利要求3所述的治疗肾虚痰湿型月经过少的药物组合物,其特征在于由下述优选重量份配比的原料药制成:巴戟天10份、熟地黄25份、刺五加15份、水茴香8份、法半夏12份、黑血藤15份、老来青25份、佛手12份、双参30份、红母鸡草15份、通经草10份、香附12份。
5.如权利要求1-4所述的治疗肾虚痰湿型月经过少的药物组合物,其特征在于所述药物组合物制成口服剂型,如片剂、薄膜衣片剂、肠溶衣片剂、胶囊剂、硬胶囊剂、软胶囊剂、口服液、颗粒剂、蜜丸剂、散剂、丹剂、溶液剂等。
6.如权利要求5所述的治疗肾虚痰湿型月经过少的药物组合物,其特征在于所述口服剂型优选为胶囊剂、片剂、颗粒剂。
7.如权利要求6所述的治疗肾虚痰湿型月经过少的药物组合物,其特征在于所述口服剂型最优选为胶囊剂。
8.如权利要求1-4所述的治疗肾虚痰湿型月经过少的药物组合物,其特征在于制备方法包括如下步骤:将水茴香、红母鸡草、通经草、香附加55%-60%的乙醇提取二次,每次1.5-2.0小时,收集乙醇提取液及乙醇提取物滤渣,减压浓缩成干浸膏,冷冻干燥,粉碎得乙醇提取物;将巴戟天、熟地黄、刺五加、法半夏、黑血藤、老来青、佛手、双参连同水茴香、红母鸡草、通经草、香附乙醇提取物滤渣加水煎煮二次,合并煎液,滤过,滤液减压浓缩至相对密度为1.05-1.10(60℃测得),加入乙醇使含醇量达35%,于0-10℃静置12小时,滤过,滤液回收乙醇后减压浓缩成干浸膏,粉碎后与水茴香、红母鸡草、通经草、香附乙醇提取物混匀,作为有效成分,该成分单独或与药物可接受的载体混合,依照制剂学常规技术制成。
9.如权利要求1-4所述的药物组合物在制备治疗肾虚痰湿型月经过少的药物中的用途。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610060138.XA CN105497400A (zh) | 2016-01-28 | 2016-01-28 | 一种治疗肾虚痰湿型月经过少的药物组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610060138.XA CN105497400A (zh) | 2016-01-28 | 2016-01-28 | 一种治疗肾虚痰湿型月经过少的药物组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105497400A true CN105497400A (zh) | 2016-04-20 |
Family
ID=55705961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610060138.XA Withdrawn CN105497400A (zh) | 2016-01-28 | 2016-01-28 | 一种治疗肾虚痰湿型月经过少的药物组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105497400A (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101085317A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 一种治疗月经过少的中成药 |
| CN101085153A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 一种治疗月经过少的中药制剂 |
| CN101810742A (zh) * | 2009-11-09 | 2010-08-25 | 刘书霞 | 用于治疗月经过少的中药制剂 |
-
2016
- 2016-01-28 CN CN201610060138.XA patent/CN105497400A/zh not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101085317A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 一种治疗月经过少的中成药 |
| CN101085153A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 一种治疗月经过少的中药制剂 |
| CN101810742A (zh) * | 2009-11-09 | 2010-08-25 | 刘书霞 | 用于治疗月经过少的中药制剂 |
Non-Patent Citations (1)
| Title |
|---|
| 侯小艳等: "孟安琪教授治疗肾虚痰湿型月经过少经验总结", 《辽宁中医药大学学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102362950A (zh) | 一种治疗白癜风的中药 | |
| CN106267120A (zh) | 一种治疗鼻炎的中药制剂及其制备方法 | |
| CN102836409B (zh) | 用于治疗产后恶露不绝的中药及制备方法 | |
| CN102178818B (zh) | 一种治疗乳腺癌的中药组合物及其制备方法 | |
| CN105250619A (zh) | 一种治疗内在性子宫内膜异位症的中药及其制备方法 | |
| CN105213906A (zh) | 一种用于治疗痛风的中药组合物及其制备方法 | |
| CN104645249B (zh) | 一种治疗冠心病心绞痛的药物 | |
| CN105381424A (zh) | 一种用于人体脏腑排毒的中药剂及制备方法 | |
| CN104771578A (zh) | 用于治疗变应性鼻炎的中药 | |
| CN105031013A (zh) | 一种治疗腰椎骨质增生的药物及其制备方法 | |
| CN104548054A (zh) | 一种治疗妇科疾病的中药组合物及其制备方法 | |
| CN102406893A (zh) | 一种治疗银屑病的中成药 | |
| CN102743543A (zh) | 治疗白带异常的中药口服制剂 | |
| CN106361981A (zh) | 一种滋阴壮阳的中药 | |
| CN104288581A (zh) | 用于治疗先兆流产的中药 | |
| CN105770691A (zh) | 一种用于治疗宫颈癌的药物制剂及其用途 | |
| CN104689067A (zh) | 一种治疗性早熟的中药组合物及其应用 | |
| CN103989994A (zh) | 用于治疗慢性荨麻疹的药物制剂 | |
| CN102552824B (zh) | 用于治疗银屑病的中成药 | |
| CN104189615B (zh) | 一种治疗崩漏的中药制剂及其制备方法 | |
| CN105497400A (zh) | 一种治疗肾虚痰湿型月经过少的药物组合物 | |
| CN105395768A (zh) | 一种治疗气血两虚型月经量少的药物组合物 | |
| CN105412825A (zh) | 一种治疗高脂血症的药物及其制备方法 | |
| CN105169111A (zh) | 一种用于治疗慢性荨麻疹的中药组合物及其应用 | |
| CN104587130A (zh) | 一种治疗急性肾小球肾炎的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160420 |
|
| WW01 | Invention patent application withdrawn after publication |